Can mRNA technology used in CIVID-19 vaccines be used to treat cancer?

One of the scientists behind the Pfizer-Bioentech vaccine – the first widely approved immunization for the novel coronavirus – claims that companies could be used to treat another deadly disease – cancer. Ozlem Turkey co-founded the German company Bioentech with him. Husband in late 2000. Bionettes, over the years, have been developing a way to fight cancer and remove tumors – the technology they were pushing to defeat the novel coronavirus. The Pfizer-Bioentech vaccine, called BNT162B2, is based on Messenger RNA (mRNA) technology, which uses chemicals. Messenger instructs cells to make proteins that mimic the outer surface of the new coronavirus, building immunity there. MRNAs rely on synthetic genes that can be produced and produced in weeks, and produce faster than conventional vaccines. The new technology was first approved for the Covid-19 vaccine; Pfizer and Bioentech MNRA Have already begun collaborating to develop technology-based influenza vaccines, which they included in BNT162B2. Israel’s population relies heavily on the Pfizer-Biantech vaccine, and at least one Kozid-5 mRNA has administered more than 5 million. Israeli citizens. Millions of doses have been administered worldwide. “It pays to make bold decisions and to believe that if you have an exceptional team, you will be able to solve any problems and obstacles that come your way in real time,” Turesi told the Associated Press.

However, there has been a clear air of vaccine hesitation – reluctance or refusal to vaccinate – among the world’s population, Teluchi told the AP that “no corners have been cut” or the stone has been left untouched while running to develop the vaccine. The rigorous process is in place and the process does not stop once the vaccine is approved, ”Teluchi told the AP. “In fact, this is happening all over the world now, where regulators have used reporting systems to evaluate screens and any observations made by us or other vaccines.” As Teluchi noted, the success of the Covid-19 vaccine off mRNA novelty technology is used not only in other vaccines, but also as a treatment for cystic fibrosis, cancer and other hard-to-treat diseases. Pfizer-Bioentech and Modern’s mRNA. Depends on technology. Say mRNA has the potential to target diseases that cannot be reached by conventional medicine. The technology is often compared to a computer operating system, allowing drug manufacturers to modify their targets by inserting new genetic codes into the manufactured form of mRNA, a natural chemical messenger that instructs the body to produce specific proteins. Its advantage in vaccines is versatility and speed compared to standard technology that requires a long lead time for the manufacture and purification of proteins and surgeons. E vaccine. Up to 150 mRNA vaccines and therapies are being developed globally, Roots Analysis said. Most of the animals are still in the initial testing, but more than 0 people have reached the human test. Working with mRNA can be very difficult, making future success uncertain through treatment. Moderina, for example, works to treat heart disease, cancer and rare. Diseases. Its most advanced non-covid program is the cytomegalovirus vaccine, the leading cause of congenital malformations in the United States. D.R. Drew Weissman, a professor of infectious diseases at the Pearlman School of Medicine at the University of Pennsylvania, is credited with discovering the 2005 discovery by two scientists on how to keep the body’s defenses stable enough to change the molecular structure of mRNA. In the last nine months, Weissman said, 20 companies working in the field of mRNA have asked him to join their board of directors, and the number of labs asking him to collaborate with Penn in the work of mRNA has almost tripled.

Reuters contributed to this report.